Skip to main content

[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH

European Journal of Nuclear Medicine and Molecular Imaging volume 39, pages 1085–1086 (2012)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Ghosh A, Heston WD. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 2004;91:528–39.

    Article  PubMed  CAS  Google Scholar 

  2. Chang SS, O’Keefe DS, Bacich DJ, Reuter VE, Heston WD, Gaudin PB. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res 1999;5:2674–81.

    PubMed  CAS  Google Scholar 

  3. Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res 1999;59:3192–8.

    PubMed  CAS  Google Scholar 

  4. Hillier SM, Maresca KP, Femia FJ, Marquis JC, Foss CA, Nguyen N, Zimmerman CN, Barrett JA, Eckelman WC, Pomper MG, Joyal JL, Babich JW. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. Cancer Res 2009;69(17):6932–40.

    Article  PubMed  CAS  Google Scholar 

  5. Eder M, Schäfer M, Bauder-Wüst U, Wängler C, Mier W, Haberkorn U, Eisenhut M. The 68Ga-complex lipophilicity and the targeting property of a urea based PSMA inhibitor for PET imaging. Bioconjug Chem 2011, in revision.

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany

    A. Afshar-Oromieh, U. Haberkorn & CM. Zechmann

  2. Department of Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany

    M. Eder & M. Eisenhut

Authors
  1. A. Afshar-Oromieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Haberkorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Eder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Eisenhut
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. CM. Zechmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to CM. Zechmann.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Afshar-Oromieh, A., Haberkorn, U., Eder, M. et al. [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH. Eur J Nucl Med Mol Imaging 39, 1085–1086 (2012). https://doi.org/10.1007/s00259-012-2069-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-012-2069-0

Keywords

  • Prostate Cancer
  • Positron Emission Tomography
  • Androgen
  • Ligand Binding
  • Urinary Bladder